The Board of Directors of Solara Active Pharma Sciences Limited, via circular resolution dated June 16, 2026, approved the allotment of 2,250 equity shares pursuant to the exercise of options under the Solara Employee Stock Option Plan 2018.
Key Details of Allotment:
- Number of shares allotted: 2,250 Equity Shares
- Face value: Rs. 10/- per share
- Exercise price: Rs. 375/- per share
- Premium per share: Rs. 365/-
- Total money realized from exercise: Rs. 8,43,750/-
- Distinctive numbers: From 48173763 To 48176012
- Date of issue: June 28, 2024
- The shares rank pari-passu with existing equity shares
Change in Paid-Up Share Capital:
- Before allotment: 4,81,73,762 shares totaling Rs. 47,98,12,464.50
- After allotment: 4,81,76,012 shares totaling Rs. 47,98,34,964.50
- The increase comprises 2,250 fully paid equity shares (Rs. 10 each)
ESOP Plan Details:
- Plan name: Solara Employee Stock Option Plan 2018
- Compliance: Under SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
- Options vested: 2,250 options (accelerated vesting post-resignation)
- Exercise period: Within 60 days from date of vesting
- Diluted EPS post-issue: Rs. 2.23 per share
Regulatory Compliance:
- Disclosure made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Also complies with Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
- Master circular reference: HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
- Original ESOP scheme filings: NSE/LIST/19224 (NSE) and DCS/IPO/JR/ESOP-IP/3352/2018-19 (BSE) on November 16, 2018
Additional Announcements:
The filing includes comprehensive annexures (Annexure-A and Annexure-B) providing detailed disclosures as required by SEBI regulations, including complete share capital breakdown and ESOP scheme particulars.